CAS RN: 63744-22-9
6,8-Dibromoimidazo[1,2-a]pyrazine
Product Availability
Choose a grade to view its available package options.
5 package records4 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250730 |
100g |
Out of stock |
| | Inquiry |
| Batchno.20250507 |
1g |
In stock |
| | Inquiry |
| Batchno.20260103 |
25g |
In stock |
| | Inquiry |
| Batchno.20250521 |
5g |
In stock |
| | Inquiry |
| Batchno.20250517 |
5g / 25g / 100g |
Confirm by inquiry |
Shanghai | 8-10 business days | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 1g, 5g, 10g, 100g, 25g, 500g
- Available purity: >97%
- Inventory rows with stock: 5
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 63744-22-9
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 1g |
>97% |
5
In Stock
|
Beijing |
Inquiry |
| 5g |
>97% |
5
In Stock
|
Hong Kong |
Inquiry |
| 10g |
>97% |
5
In Stock
|
Shanghai |
Inquiry |
| 100g |
>97% |
5
In Stock
|
Beijing |
Inquiry |
| 25g |
>97% |
4
In Stock
|
Hong Kong |
Inquiry |
| 500g |
>97% |
0
Out of Stock
|
Shanghai |
Inquiry |
63744-22-9 / 6,8-dibromoimidazo[1,2-a]pyrazine
Standard CAS: 63744-22-9
Multi CAS: No
Basic Information
CAS
63744-22-9
Multi CAS
No
Molecular Formula
C6H3BR2N3
Molecular Weight
276.920000
Exact Mass
276.867320
InChI
InChI=1S/C6H3Br2N3/c7-4-3-11-2-1-9-6(11)5(8)10-4/h1-3H
InChIKey
UQCZZGIPIMJBCL-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
11
Aromatic heavy atom count
9
H-bond acceptors
3
Molar refractivity
48.39
TPSA
30.19
LogP / Solubility
WLOGP
2.25
MLOGP
1.99
XLogP3
2.7
Consensus LogP
2.31
Log S (ESOL)
-3.58
Class (ESOL)
Poorly soluble
Log S (Ali)
-3.46
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-3.33
Class (SILICOS-IT)
Poorly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.81
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
Yes
Synthetic Accessibility
1.5